High hepatic expression of PDK4 improves survival upon multimodal treatment of colorectal liver metastases

BACKGROUND: Patients with borderline resectable colorectal liver metastases (CRLM) frequently receive neoadjuvant chemotherapy (NC) to reduce tumour burden, thus making surgical resection feasible. Even though NC can induce severe liver injury, most studies investigating tissue-based prognostic mark...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Cancer
Asıl Yazarlar: Strowitzki, Moritz J., Radhakrishnan, Praveen, Pavicevic, Sandra, Scheer, Jana, Kimmer, Gwendolyn, Ritter, Alina S., Tuffs, Christopher, Volz, Claudia, Vondran, Florian, Harnoss, Jonathan M., Klose, Johannes, Schmidt, Thomas, Schneider, Martin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6461828/
https://ncbi.nlm.nih.gov/pubmed/30808993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0406-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller